 NEWTON, Mass., Feb. 01, 2022 GLOBE NEWSWIRE -- Acer Therapeutics Inc. Nasdaq: ACER, a pharmaceutical company focused on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today announced that Acers management team will virtually participate in the BIO CEO Investor Conference on February 14-17, 2022. 